|
Volumn 49, Issue 43, 2002, Pages 79-86
|
Hepatic artery chemoembolization for advanced stage hcc: Experience of 650 patients
|
Author keywords
Chemoembolization; Cisplatin; Hepatocellular carcinoma; Prognosis; Responses
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY;
GELFOAM;
GEMCITABINE;
GEMSAR;
HEPATITIS VACCINE;
IODINATED POPPYSEED OIL;
IODINE 131;
MITOMYCIN C;
STREPTOZOCIN;
THALIDOMIDE;
VINCRISTINE;
YTTRIUM 90;
ZINOSTATIN;
ARTIFICIAL EMBOLISM;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CAUSE OF DEATH;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
GENE THERAPY;
HEPATIC ARTERY;
HEPATITIS;
HUMAN;
LIVER CELL CARCINOMA;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
TREATMENT OUTCOME;
VACCINATION;
ANTINEOPLASTIC AGENTS;
CARCINOMA, HEPATOCELLULAR;
CHEMOEMBOLIZATION, THERAPEUTIC;
CISPLATIN;
GELATIN SPONGE, ABSORBABLE;
HEPATIC ARTERY;
HUMANS;
INFUSIONS, INTRA-ARTERIAL;
LIVER CIRRHOSIS;
LIVER NEOPLASMS;
NEOPLASM INVASIVENESS;
NEOPLASM STAGING;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 0036217463
PISSN: 01726390
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (53)
|
References (22)
|